30% off. Use code at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Mats Blom

Track

Insider profile

Performance

Overall performance

0.7

Performance over holding periods

0.7

	30 days	90 days	120 days
Average return	-2%	8.2%	15.1%
Success rate	0%	68%	82%
Transactions	1 100% Buy	34 71% Buy	47 69% Buy

Ranking by holding-period performance

Search

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-01-16	2026-01-14	Rare Thyroid Therapeutics International AB	B Purchase	20,268 104.66 SEK1,061,835	20,268	104.66	SEK1,061,835
2025-11-27	2025-11-26	Rare Thyroid Therapeutics International AB	B Purchase	1,637 254.84 SEK4,723,281	1,637	254.84	SEK4,723,281
2025-11-27	2025-11-26	Egetis Therapeutica AB	B Purchase	98,257 499.08 SEK4,337,495	98,257	499.08	SEK4,337,495
2025-11-27	2025-11-25	Rare Thyroid Therapeutics International AB	B Purchase	180,000 5.24 SEK943,200	180,000	5.24	SEK943,200
2025-11-27	2025-11-25	Egetis Therapeutica AB	B Purchase	180,000 5.24 SEK943,200	180,000	5.24	SEK943,200
2023-05-31	2023-05-31	Rare Thyroid Therapeutics International AB	B Purchase	200,000 4.96 SEK991,600	200,000	4.96	SEK991,600
2022-05-19	2022-05-17	Rare Thyroid Therapeutics International AB	B Purchase	677,250 3.65 SEK2,471,962	677,250	3.65	SEK2,471,962
2019-11-04	2019-11-04	Hansa Biopharma AB (HNSA)	B Purchase	1,000 123.17 SEK123,170	1,000	123.17	SEK123,170